Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( August )
Competency-based interviewing: Selling your skillset
Drawing on your previous triumphs and failures can help you prove you're up to the job. But preparation is the key to success.(more)
Welcome to the real world
Matthew Gordon examines the differences between observational studies and phase III clinical trials(more)
Drug regulation: still room for improvement
The Medicines Act is 40 years old this year, but regulations and regulators have to change to keep up with rapid changes in medicines and society, says Les Rose.(more)
PharmafocusNews Register for New Alert
News for April 2004
Previous Months: July 2008 |  June 2008 |  May 2008 |  April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Patients still being denied access to colon cancer treatments
Survey highlights NHS problems..(more)

 NHS finances a cause for concern, says watchdog
PCTs handed massive financial agenda..(more)

 Burson-Marsteller to launch cancer treatment in the UK
BM to raise Velcade's awareness..(more)

 Wyeth's Zoton hot on the heels of over-the-counter Zanprol
Zoton more effective than Zanprol..(more)

 No change one year on from NSF, says diabetes charity
Pharma companies note little direct action ..(more)

 A tale of two pills for Pfizer in Q1
Lilly's Cialis gains ground on Viagra..(more)

 BMA chairman warns reforms add to threat of 'two-tier NHS'
Survey shows patients value choice..(more)

 US legal action Aventis' latest weapon in repelling Sanofi
Sanofi dismisses lawsuit..(more)

 Aventis' Apidra approved in US
Aventis expands diabetes portfolio..(more)

 Merck and S-P's cholesterol combination approved in Germany
Efficacy stressed over safety..(more)

 Avastin gets off to a flying start
Genentech posts strong results..(more)

 Humira gives Abbott a shot in the arm
US pharma sales rise 24%..(more)

 Britannia and Otsuka collaborate on autoimmune disease treatment
Adacolumn to be distributed in UK..(more)

 Sanofi slims down portfolio in preparation for Aventis acquisition
Sanofi agrees drug sale to GSK..(more)

 Heart concerns halt Acambis trials
Product licence could be delayed..(more)

 Another April revolution to transform the NHS
Devolution and reform continues..(more)

 Lilly's 'Le Weekender' gaining ground on Viagra
Cialis gains ground in US..(more)

 Aventis invites Novartis 'white knight' bid
French government maintains stance..(more)

 NHS drugs spend still lagging behind European neighbours
Postcode prescribing still major problem..(more)

 New 'harmonising' NHS watchdog begins work
More independent Commission set up..(more)

 Contract underway but GPs gloomy about the future of health service
Patient choice increasingly important..(more)

 Crestor hits 'a bump in the road' as BMS study backfires
Analysts dismiss setback..(more)

 Medical magazines most useful form of communication, say GPs
Survey seeks to reverse fall in ad spend..(more)

 US accused of blocking generics AIDS drug plan
Aid agency criticises US government ..(more)

 Blockbusters lose UK patent battle to generic competitors
GSK under generics pressure..(more)

 Amgen pipeline boosted by $1.3bn Tularik acquisition
Amgen buys gene regualtion specialist..(more)

 GSK launch over-the-counter omeprazole as Zanprol
Government backes omeprazole switch..(more)

 Britain to support science and R&D with ten-year plan
Pharma giants to invest..(more)

 New antidepressant warnings in US and Britain
MHRA comes under fire..(more)

 Pfizer's next blockbuster Lyrica closer to EU launch
New drug to match Neurotin sales..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.